Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Why Shares of Immuneering Jumped This Week
Jim Halley
|
Mar 24, 2023
Immuneering is ready to share information regarding its lead therapy.
3 Stocks That Could Double Your Money
Cory Renauer
|
Jul 26, 2018
Find out why these three biotech stocks could be huge winners.
Why Galectin Therapeutics Stock Bolted Higher Today
George Budwell
|
Jun 27, 2018
Galectin's new patent for its lead drug candidate sent its shares higher today.
2 Clinical-Stage Biotech Stocks That Could Soar Next Week
George Budwell
|
Jun 17, 2018
Shares of Galectin Therapeutics and Verastem should both head higher in the coming week. Here's why.
3 NASH Stocks That Could Soar in the Second Half of 2018
Cory Renauer
|
Jun 15, 2018
The first treatments for this growing epidemic of liver disease will be huge blockbusters, and one of these biotechs could have what it takes.
Why Galectin Therapeutics Inc. Shares Jumped
Sean Williams
|
Apr 17, 2014
Galectin shares soar following the company's dosing of its first patient in a second phase 1 cohort. Here's what shareholders should really be watching.
Why Plug Power, Varonis Systems, and Galectin Therapeutics Are Today's 3 Best Stocks
Sean Williams
|
Mar 25, 2014
Consumer confidence hits a six-year high, adding fuel to the huge run-ups for Plug Power, Varonis Systems, and Galectin Therapeutics.
Why Galectin Therapeutics, Inc. Shares Soared
Sean Williams
|
Mar 25, 2014
Galectin sets the date for the release of its phase 1 study data on GR-MD-02 for nonalcoholic steatohepatitis. Find out what shareholders should really be waiting for.
Today's Biggest Stories in Biotech: Galectin Therapeutics Inc, Merrimack Pharmaceuticals and Nektar Therapeutics
George Budwell
|
Feb 27, 2014
Top stories in biotech and healthcare today.
Why Inteliquent, Pacific Biosciences of California, and Galectin Therapeutics Are Today's 3 Best Stocks
Sean Williams
|
Jan 21, 2014
The S&P 500 advances modestly on strong earnings results as Inteliquent, Pacific Biosciences of California, and Galectin Therapeutics jumped by at least 15%.
View More Articles